OpenAI acquires Orchestra Bio

Summary

OpenAI has acquired Orchestra Bio, a platform that helps biopharma teams coordinate drug development. OpenAI plans to combine Orchestra's team and technology with Rosalind, its AI models and tools for life sciences research. The stated goal is to help scientists make discoveries and get new treatments to patients sooner.

Related items

• InfoJudge dismisses Sam Altman’s sister’s sexual abuse lawsuitSame vendor · The Verge (AI)
• InfoOpenAI CEO Sam Altman wins dismissal of sister's lawsuitSame vendor · BBC Technology
• InfoEx-OpenAI Engineer Detained After Planting Secret Recorder at HQSame vendor · Dark Reading
• InfoAmericans, this is your chance to slap down the tech broligarchsSame vendor · The Guardian Technology
• InfoOpenAI says GPT-6.1 Sol is dramatically better at migrating legacy codeSame vendor · BleepingComputer